BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8535938)

  • 1. Treatment for impotence gains FDA approval.
    Am J Health Syst Pharm; 1995 Oct; 52(19):2078-9. PubMed ID: 8535938
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of prostaglandins for diagnosis and treatment of erectile impotence.
    Merckx L; Vanwaeyenbergh J; De Bruyne R; Braeckman J; Keuppens F
    Acta Urol Belg; 1991; 59(3):47-52. PubMed ID: 1759665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 4. Intracavernous injection of alprostadil for erectile dysfunction.
    Med Lett Drugs Ther; 1995 Sep; 37(958):83-4. PubMed ID: 7674992
    [No Abstract]   [Full Text] [Related]  

  • 5. Can self-injection therapy cure impotence?
    Sharlip ID
    Adv Exp Med Biol; 1997; 433():83-6. PubMed ID: 9561109
    [No Abstract]   [Full Text] [Related]  

  • 6. Impotence.
    Lue TF; Levine JD
    J Urol; 1995 Jul; 154(1):85. PubMed ID: 7776462
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intracavernous injections of prostaglandin E1 in the treatment of erection disorders].
    Beretta G; Zanollo A; Portalupi W
    Arch Ital Urol Nefrol Androl; 1991 Dec; 63(4):481-5. PubMed ID: 1838836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraurethral alprostadil for impotence.
    Med Lett Drugs Ther; 1997 Mar; 39(997):32. PubMed ID: 9121395
    [No Abstract]   [Full Text] [Related]  

  • 9. Intracavernous injection of prostaglandin E1 in spinal cord injured patients with erectile dysfunction. A preliminary report.
    Tang SF; Chu NK; Wong MK
    Paraplegia; 1995 Dec; 33(12):731-3. PubMed ID: 8927414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
    Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erectile dysfunction.
    O'Leary M
    Clin Evid; 2002 Jun; (7):796-803. PubMed ID: 12230705
    [No Abstract]   [Full Text] [Related]  

  • 12. Intracavernosal injection of pharmacological agents in the diagnosis and treatment of impotence.
    Siraj QH; Akhtar MA
    J Pak Med Assoc; 1989 Jul; 39(7):172-6. PubMed ID: 2504962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostaglandin E1 in the long-term treatment of erectile dysfunction].
    Vrabec J
    Bratisl Lek Listy; 1992 Oct; 93(10):545-6. PubMed ID: 1288824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transurethral alprostadil with MUSE (medicated urethral system for erection) vs intracavernous alprostadil--a comparative study in 103 patients with erectile dysfunction.
    Lewis RW
    Int J Impot Res; 1998 Mar; 10(1):61-2. PubMed ID: 9542692
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intracavernous auto-injection of prostaglandin E1 for diagnosis and treatment of erectile dysfunction].
    Arielly J; Weinberg D; Eliraz A; Adam M; el-Hanani BI; Eisenkraft S
    Harefuah; 1994 Apr; 126(7):369-73, 426. PubMed ID: 8200581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E1 in the therapy of erectile deficiency.
    Beretta G; Zanollo A; Ascani L; Re B
    Acta Eur Fertil; 1989; 20(5):305-8. PubMed ID: 2636808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erectile dysfunction.
    O'Leary M;
    Clin Evid; 2002 Dec; (8):872-80. PubMed ID: 15259177
    [No Abstract]   [Full Text] [Related]  

  • 18. [Initial experiences with prostaglandin E1 and PGE1 prepared injections].
    Mattarelli G; Leibundgut B
    Helv Chir Acta; 1991 Sep; 58(3):335-7. PubMed ID: 1769856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of erectile impotence in renal transplant patients with intracavernosal vasoactive drugs.
    Rodriguez Antolin A; Morales JM; Andrés A; Fernández Aparicio T; Díaz González R; Pamplona M; Alvarez E
    Transplant Proc; 1992 Feb; 24(1):105-6. PubMed ID: 1539195
    [No Abstract]   [Full Text] [Related]  

  • 20. Relation between intracavernosal dose of prostaglandin Pge 1 and mean duration of erection in men with different underlying causes of erectile dysfunction.
    Bratus D; Hlebic G; Hajdinjak T
    Croat Med J; 2007 Feb; 48(1):76-80. PubMed ID: 17309142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.